Researchers relied on a newer gene-editing technique that may make it possible to engineer embryos, a prospect that has long ...
Eli Lilly's pipeline is an embarrassment of riches.
One company dominates with an approved therapy, while the other bets on in vivo innovation. See how their financials and risk ...
Morning Overview on MSN
Disabling NFIL3 via CRISPR kept engineered CAR T-cells from hitting exhaustion, prolonging tumor control in animal models
Researchers at Columbia University’s Sadelain lab and University Hospital Tubingen used CRISPR gene editing to knock out the ...
A team in the US has reported promising results after using an improved form of CRISPR to gene-edit human embryos, but a ...
For years, CRISPR Therapeutics (CRSP 1.25%) has been the type of stock investors might call a home run swing. The company ...
News Nation on MSN
Scientists achieve most precise human embryo DNA edit to date
The breakthrough could one day allow doctors to repair disease-causing mutations in embryos.
Stanford Medicine researchers have developed an artificial intelligence tool to help scientists better plan gene-editing experiments. The technology, CRISPR-GPT, acts as a gene-editing "copilot" ...
The gene-editing niche of the biotech industry is gaining momentum, as various companies focused on these techniques -- which ...
It has also aggressively invested in gene editing, including its 2025 acquisition of cardiovascular disease gene-editing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results